FDA Import Refusal AEK-5098998-5/21/1 — US BOEHRINGER
The FDA refused shipment AEK-5098998-5/21/1 from US BOEHRINGER (United States) on May 22, 2024. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- May 22, 2024
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75